Mantle Cell Lymphoma
Clinical Characteristics, Prevalence & Treatment Options
Seiten
2015
Nova Science Publishers Inc (Verlag)
978-1-63482-363-0 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63482-363-0 (ISBN)
Mantle cell lymphoma (MCL) is a subtype of Non-Hodgkin's Lymphoma (NHL) with varying clinical presentations, ranging from indolent disease to highly aggressive symptoms. MCL represents approximately 3-10% of non-Hodgkin lymphomas, and has increased in incidence over the past several decades. The majority of patients respond to initial therapy, but remission duration is typically short. This book discusses the clinical characteristics of mantle cell lymphoma, as well as its prevalence and examines several treatment options available.
Preface; Diagnosis, Prognosis & Genetic Features of Mantle Cell Lymphoma; Mantle Cell Lymphoma: Current Treatment Strategies in the Era of Targeted Agents; Targeted Drugs in the Treatment of Mantle Cell Lymphoma; Emerging Role of Novel Agents in the Treatment of Mantle Cell Lymphoma; Current Place of Proteasome Inhibitors in the Treatment of Mantle Cell Lymphoma; Index.
Erscheint lt. Verlag | 1.6.2015 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 155 x 230 mm |
Gewicht | 328 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
ISBN-10 | 1-63482-363-X / 163482363X |
ISBN-13 | 978-1-63482-363-0 / 9781634823630 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00